Clinical Trials in Los Angeles

Showing 8281-8300 of 12,794 trials

ST266 Versus Standard Care In Treating Partial Thickness Burns

NCT00886470

The objective of this protocol is to perform a safety and dose-determination efficacy clinical trial in patients having a degree of partial-thickness burn wounds. The trial will be a prospectively randomized and double-blind trial of ST266 compared with standardized care using 0.9% NaCl (normal saline) solution in the same three treatment regimens.

Burns

Noveome Biotherapeutics, formerly Stemnion16 participantsStarted Jun 2009

Mobile, Alabama, United States • Los Angeles, California, United States • Gainesville, Florida, United States +11 more locations

TERMINATEDPhase 2< 1 mile

STOP Heart Disease in Breast Cancer Survivors Trial

NCT02674204

The purpose of this study is to to examine the effects of atorvastatin, a type of statin, on changes to the heart among women undergoing breast cancer treatment. Atorvastatin may reduce or eliminate the harmful effects of chemotherapy treatment to the heart tissue of breast cancer patients.

Breast CancerHeart DiseaseCardiotoxicity+1 more

Cedars-Sinai Medical Center2 participantsStarted May 2016

Los Angeles, California, United States

ST266 Versus Standard Care In Treating Partial Thickness Burns

STOP Heart Disease in Breast Cancer Survivors Trial

Find Trials by Condition in Los Angeles

Fenzian Asthma Multicenter Outcomes Study

Surgical Indirect Revascularization For Symptomatic Intracranial Arterial Stenosis

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures.

Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DM

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

The vBlocT2D Study

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Epidemiologic Analysis of Change in Eyelash Characteristics With Age in Healthy Women

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Participants With Liver Fibrosis

A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

MEmbranous Nephropathy Trial Of Rituximab